A Map of Alzheimer's Disease–Signaling Pathways: A Hope for Drug Target Discovery

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical pharmacology and therapy

• Publication date

  2013-05-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1038/clpt.2013.37PMID 23511713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks

  2008cited by this paper
• A robustness-based approach to systems-oriented drug design

  2007cited by this paper
• The CA1 Region of the Human Hippocampus Is a Hot Spot in Alzheimer's Disease

  2000cited by this paper
• What is a community?

  1998cited by this paper
• Bioinformatics Applications Note Systems Biology Payao: a Community Platform for Sbml Pathway Model Curation

  year unknowncited by this paper

• The Art of Finding the Right Drug Target: Emerging Methods and Strategies

  2024cites this paper
• Replication study of plasma proteins relating to Alzheimer’s 1 pathology

  2021cites this paper
• Replication study of plasma proteins relating to Alzheimer's pathology

  2021cites this paper
• Identification of plasma proteins relating to brain neurodegeneration and vascular pathology in cognitively normal individuals

  2021cites this paper
• Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease

  2019cites this paper
• Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

  2019cites this paper
• Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future

  2018cites this paper
• Building multiscale computable model of Alzheimer's disease and identification of novel mechanisms for new therapeutic interventions

  2018cites this paper
• Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer’s Disease

  2018cites this paper
• Profiling of Human Molecular Pathways Affected by Retrotransposons at the Level of Regulation by Transcription Factor Proteins

  2018cites this paper
• Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes

  2017cites this paper
• The APP Proteolytic System and Its Interactions with Dynamic Networks in Alzheimer's Disease.

  2016cites this paper
• Sex-specific patterns and differences in dementia and Alzheimer’s disease using informatics approaches

  2016cites this paper
• Neurological Diseases from a Systems Medicine Point of View.

  2016cites this paper
• Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer’s Disease

  2016cites this paper
• Network Approaches to the Understanding of Alzheimer's Disease: From Model Organisms to Humans.

  2016cites this paper
• Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks.

  2016cites this paper
• Systems Medicine

  2016cites this paper
• A Human-Based Integrated Framework forAlzheimer’s Disease Research

  2015cites this paper
• Computable cause‐and‐effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis

  2015cites this paper
• Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease

  2014cites this paper
• Considering a new paradigm for Alzheimer's disease research.

  2014cites this paper
• Current advances in systems and integrative biology

  2014cites this paper
• Using large-scale text mining for a systematic reconstruction of molecular mechanisms of diseases : a case study in thyroid cancer

  2014cites this paper
• esyN: Network Building, Sharing and Publishing

  2014cites this paper
• Molecular Insights Provide the Critical Path to Disease Mitigation

  2013cites this paper
• A network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effect

  2013cites this paper